Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CERVICAL DILATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CERVICAL DILATOR MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CERVICAL DILATOR MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER'S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNOLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 INSTALLED BASE DATA
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 GLOBAL CERVICAL DILATOR MARKET, BY TYPE
17.1 OVERVIEW
17.2 HEGER CERVICAL DILATOR
17.2.1 BY PRODUCT
17.2.1.1. SINGLE ENDED
17.2.1.2. DOUBLE ENDED
17.2.2 BY SIZE
17.2.2.1. BELOW 11MM/12MM
17.2.2.2. 11MM/12MM- 15/16MM
17.2.2.3. ABOVE 15MM/16MM
17.2.3 BY SHAPE
17.2.3.1. ROUND HOLLOW
17.2.3.2. SLIGHTLY CURVED
17.2.3.3. NON-FLEXIBLE
17.3 PRATT CERVICAL DILATOR
17.3.1 BY SIZE
17.3.1.1. BELOW 25/27 FR
17.3.1.2. 25/27FR -49/51 FR
17.3.1.3. ABOVE 49/51 FR
17.4 HANK CERVICAL DILATOR
17.4.1 BY SIZE
17.4.1.1. BELOW 13/14 FR
17.4.1.2. 13/14 FR -17/18 FR
17.4.1.3. ABOVE 17/18 FR
17.5 BALLON CERVICAL DILATOR
17.5.1 BY SIZE
17.5.1.1. 5MM
17.5.1.2. 7MM
17.5.1.3. 9MM
17.6 UTERINE ENDOCERVICAL CURETTE
17.6.1 BY TIP TYPE
17.6.1.1. SQUARE TIP
17.6.1.2. ROUND TIP
17.6.2 BY TYPE
17.6.2.1. TOWNSEND METAL UTERINE ENDOCERVICAL CURETTE
17.6.2.2. SPIRAL ENDOCERVICAL CURETTE
17.6.2.3. OTHERS
17.7 OSMOTIC CERVICAL DILATOR
17.8 OTHERS
18 GLOBAL CERVICAL DILATOR MARKET, BY PRODUCT MATERIAL
18.1 OVERVIEW
18.2 METAL CERVICAL DILATORS
18.2.1 STAINLESS STEEL
18.2.2 TITANIUM
18.2.3 OTHERS
18.3 NON-METAL CERVICAL DILATORS
18.3.1 PLASTIC AND RESINS
18.3.2 RUBBER
18.3.3 OSMOTIC (HYDROGEL)
18.3.4 OTHERS
19 GLOBAL CERVICAL DILATOR MARKET, BY USABILITY
19.1 OVERVIEW
19.2 REUSABLE
19.3 DISPOSABLE
20 GLOBAL CERVICAL DILATOR MARKET, BY STERILITY
20.1 OVERVIEW
20.2 STERILE
20.3 NON STERILE
21 GLOBAL CERVICAL DILATOR MARKET,BY SIZE
21.1 OVERVIEW
21.2 SMALL
21.3 MEDIUM
21.4 LARGE
22 GLOBAL CERVICAL DILATOR MARKET, BY APPLICATION
22.1 OVERVIEW
22.2 TREATMENT
22.2.1 INDUCTION OF LABOR
22.2.1.1. METAL CERVICAL DILATORS
22.2.1.2. NON-METAL CERVICAL DILATORS
22.2.2 PREGNANCY TERMINATION
22.2.2.1. METAL CERVICAL DILATORS
22.2.2.2. NON-METAL CERVICAL DILATORS
22.2.3 UTERINE CURETTAGE
22.2.3.1. METAL CERVICAL DILATORS
22.2.3.2. NON-METAL CERVICAL DILATORS
22.2.4 PLACEMENT AND REMOVAL OF INTRAUTERINE DEVICES
22.2.4.1. METAL CERVICAL DILATORS
22.2.4.2. NON-METAL CERVICAL DILATORS
22.2.5 OTHERS
22.3 DIAGNOSTICS
22.3.1 CERVICAL CANCER DIAGNOSIS
22.3.1.1. METAL CERVICAL DILATORS
22.3.1.2. NON-METAL CERVICAL DILATORS
22.3.2 OTHERS
23 GLOBAL CERVICAL DILATOR MARKET, BY END USER
23.1 OVERVIEW
23.2 HOSPITALS
23.3 SPECIALTY CLINICS
23.4 AMBULATORY SURGICAL CENTERS
23.5 TRAUMA CENTERS
23.6 DIAGNOSTIC CENTERS
23.7 ACADEMIC AND RESEARCH INSTITUTES
23.8 OTHERS
24 GLOBAL CERVICAL DILATOR MARKET, BY DISTRIBUTION CHANNEL
24.1 OVERVIEW
24.2 DIRECT TENDERS
24.3 RETAIL SALES
24.3.1 HOSPITAL PHARMACIES
24.3.2 DRUG STORES
24.3.3 ONLINE PHARMACIES
24.3.4 OTHERS
24.4 OTHERS
25 GLOBAL CERVICAL DILATOR MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.2 COMPANY SHARE ANALYSIS: EUROPE
25.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
25.4 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
25.5 COMPANY SHARE ANALYSIS: SOUTH AMERICA
25.6 MERGERS & ACQUISITIONS
25.7 NEW PRODUCT DEVELOPMENT & APPROVALS
25.8 EXPANSIONS
25.9 REGULATORY CHANGES
25.1 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26 GLOBAL CERVICAL DILATOR MARKET, SWOT AND DBMR ANALYSIS
27 GLOBAL CERVICAL DILATOR MARKET, BY REGION
GLOBAL CERVICAL DILATOR MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
27.1 NORTH AMERICA
27.1.1 U.S.
27.1.2 CANADA
27.1.3 MEXICO
27.2 EUROPE
27.2.1 GERMANY
27.2.2 FRANCE
27.2.3 U.K.
27.2.4 HUNGARY
27.2.5 LITHUANIA
27.2.6 AUSTRIA
27.2.7 IRELAND
27.2.8 NORWAY
27.2.9 POLAND
27.2.10 ITALY
27.2.11 SPAIN
27.2.12 RUSSIA
27.2.13 TURKEY
27.2.14 NETHERLANDS
27.2.15 SWITZERLAND
27.2.16 REST OF EUROPE
27.3 ASIA-PACIFIC
27.3.1 JAPAN
27.3.2 CHINA
27.3.3 SOUTH KOREA
27.3.4 INDIA
27.3.5 AUSTRALIA
27.3.6 SINGAPORE
27.3.7 THAILAND
27.3.8 MALAYSIA
27.3.9 INDONESIA
27.3.10 PHILIPPINES
27.3.11 VIETNAM
27.3.12 REST OF ASIA-PACIFIC
27.4 SOUTH AMERICA
27.4.1 BRAZIL
27.4.2 ARGENTINA
27.4.3 PERU
27.4.4 COLOMBIA
27.4.5 VENEZUELA
27.4.6 REST OF SOUTH AMERICA
27.5 MIDDLE EAST AND AFRICA
27.5.1 SOUTH AFRICA
27.5.2 SAUDI ARABIA
27.5.3 UAE
27.5.4 EGYPT
27.5.5 KUWAIT
27.5.6 ISRAEL
27.5.7 REST OF MIDDLE EAST AND AFRICA
27.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
28 GLOBAL CERVICAL DILATOR MARKET, COMPANY PROFILE
28.1 INTEGRA LIFESCIENCES
28.1.1 COMPANY OVERVIEW
28.1.2 REVENUE ANALYSIS
28.1.3 GEOGRAPHIC PRESENCE
28.1.4 PRODUCT PORTFOLIO
28.1.5 RECENT DEVELOPMENTS
28.2 COOPER SURGICAL
28.2.1 COMPANY OVERVIEW
28.2.2 REVENUE ANALYSIS
28.2.3 GEOGRAPHIC PRESENCE
28.2.4 PRODUCT PORTFOLIO
28.2.5 RECENT DEVELOPMENTS
28.3 GERMEDUSA
28.3.1 COMPANY OVERVIEW
28.3.2 REVENUE ANALYSIS
28.3.3 GEOGRAPHIC PRESENCE
28.3.4 PRODUCT PORTFOLIO
28.3.5 RECENT DEVELOPMENTS
28.4 MEDGYN PRODUCTS
28.4.1 COMPANY OVERVIEW
28.4.2 REVENUE ANALYSIS
28.4.3 GEOGRAPHIC PRESENCE
28.4.4 PRODUCT PORTFOLIO
28.4.5 RECENT DEVELOPMENTS
28.5 MEDICEM, INC.
28.5.1 COMPANY OVERVIEW
28.5.2 REVENUE ANALYSIS
28.5.3 GEOGRAPHIC PRESENCE
28.5.4 PRODUCT PORTFOLIO
28.5.5 RECENT DEVELOPMENTS
28.6 SKLAR SURGICAL INSTRUMENTS
28.6.1 COMPANY OVERVIEW
28.6.2 REVENUE ANALYSIS
28.6.3 GEOGRAPHIC PRESENCE
28.6.4 PRODUCT PORTFOLIO
28.6.5 RECENT DEVELOPMENTS
28.7 NOVO SURGICAL INC.
28.7.1 COMPANY OVERVIEW
28.7.2 REVENUE ANALYSIS
28.7.3 GEOGRAPHIC PRESENCE
28.7.4 PRODUCT PORTFOLIO
28.7.5 RECENT DEVELOPMENTS
28.8 HOLOGIC, INC
28.8.1 COMPANY OVERVIEW
28.8.2 REVENUE ANALYSIS
28.8.3 GEOGRAPHIC PRESENCE
28.8.4 PRODUCT PORTFOLIO
28.8.5 RECENT DEVELOPMENTS
28.9 PANPAC MEDICAL CORP.
28.9.1 COMPANY OVERVIEW
28.9.2 REVENUE ANALYSIS
28.9.3 GEOGRAPHIC PRESENCE
28.9.4 PRODUCT PORTFOLIO
28.9.5 RECENT DEVELOPMENTS
28.1 MARINA MEDICAL INC.
28.10.1 COMPANY OVERVIEW
28.10.2 REVENUE ANALYSIS
28.10.3 GEOGRAPHIC PRESENCE
28.10.4 PRODUCT PORTFOLIO
28.10.5 RECENT DEVELOPMENTS
28.11 MEDLINE INDUSTRIES, LP.
28.11.1 COMPANY OVERVIEW
28.11.2 REVENUE ANALYSIS
28.11.3 GEOGRAPHIC PRESENCE
28.11.4 PRODUCT PORTFOLIO
28.11.5 RECENT DEVELOPMENTS
28.12 AMBLER SURGICAL
28.12.1 COMPANY OVERVIEW
28.12.2 REVENUE ANALYSIS
28.12.3 GEOGRAPHIC PRESENCE
28.12.4 PRODUCT PORTFOLIO
28.12.5 RECENT DEVELOPMENTS
28.13 SURTEX INSTRUMENTS LIMITED
28.13.1 COMPANY OVERVIEW
28.13.2 REVENUE ANALYSIS
28.13.3 GEOGRAPHIC PRESENCE
28.13.4 PRODUCT PORTFOLIO
28.13.5 RECENT DEVELOPMENTS
28.14 ADVIN HEALTH CARE
28.14.1 COMPANY OVERVIEW
28.14.2 REVENUE ANALYSIS
28.14.3 GEOGRAPHIC PRESENCE
28.14.4 PRODUCT PORTFOLIO
28.14.5 RECENT DEVELOPMENTS
28.15 STERIS
28.15.1 COMPANY OVERVIEW
28.15.2 REVENUE ANALYSIS
28.15.3 GEOGRAPHIC PRESENCE
28.15.4 PRODUCT PORTFOLIO
28.15.5 RECENT DEVELOPMENTS
28.16 SURGICAL HOLDINGS.
28.16.1 COMPANY OVERVIEW
28.16.2 REVENUE ANALYSIS
28.16.3 GEOGRAPHIC PRESENCE
28.16.4 PRODUCT PORTFOLIO
28.16.5 RECENT DEVELOPMENTS
28.17 GTIMD CATHETER SOLUTIONS
28.17.1 COMPANY OVERVIEW
28.17.2 REVENUE ANALYSIS
28.17.3 GEOGRAPHIC PRESENCE
28.17.4 PRODUCT PORTFOLIO
28.17.5 RECENT DEVELOPMENTS
28.18 COOK
28.18.1 COMPANY OVERVIEW
28.18.2 REVENUE ANALYSIS
28.18.3 GEOGRAPHIC PRESENCE
28.18.4 PRODUCT PORTFOLIO
28.18.5 RECENT DEVELOPMENTS
28.19 SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
28.19.1 COMPANY OVERVIEW
28.19.2 REVENUE ANALYSIS
28.19.3 GEOGRAPHIC PRESENCE
28.19.4 PRODUCT PORTFOLIO
28.19.5 RECENT DEVELOPMENTS
28.2 THOMAS MEDICAL.
28.20.1 COMPANY OVERVIEW
28.20.2 REVENUE ANALYSIS
28.20.3 GEOGRAPHIC PRESENCE
28.20.4 PRODUCT PORTFOLIO
28.20.5 RECENT DEVELOPMENTS
28.21 SURGIPRO, INC.
28.21.1 COMPANY OVERVIEW
28.21.2 REVENUE ANALYSIS
28.21.3 GEOGRAPHIC PRESENCE
28.21.4 PRODUCT PORTFOLIO
28.21.5 RECENT DEVELOPMENTS
28.21.6 COMPANY OVERVIEW
28.21.7 REVENUE ANALYSIS
28.21.8 GEOGRAPHIC PRESENCE
28.21.9 PRODUCT PORTFOLIO
28.21.10 RECENT DEVELOPMENTS
28.22 LABORIE
28.22.1 COMPANY OVERVIEW
28.22.2 REVENUE ANALYSIS
28.22.3 GEOGRAPHIC PRESENCE
28.22.4 PRODUCT PORTFOLIO
28.22.5 RECENT DEVELOPMENTS
28.23 MEDESIGN I.C. GMBH
28.23.1 COMPANY OVERVIEW
28.23.2 REVENUE ANALYSIS
28.23.3 GEOGRAPHIC PRESENCE
28.23.4 PRODUCT PORTFOLIO
28.23.5 RECENT DEVELOPMENTS
28.24 GYNEDIL.COM
28.24.1 COMPANY OVERVIEW
28.24.2 REVENUE ANALYSIS
28.24.3 GEOGRAPHIC PRESENCE
28.24.4 PRODUCT PORTFOLIO
28.24.5 RECENT DEVELOPMENTS
28.25 TELEFLEX INCORPORATED
28.25.1 COMPANY OVERVIEW
28.25.2 REVENUE ANALYSIS
28.25.3 GEOGRAPHIC PRESENCE
28.25.4 PRODUCT PORTFOLIO
28.25.5 RECENT DEVELOPMENTS
28.26 GYNEX
28.26.1 COMPANY OVERVIEW
28.26.2 REVENUE ANALYSIS
28.26.3 GEOGRAPHIC PRESENCE
28.26.4 PRODUCT PORTFOLIO
28.26.5 RECENT DEVELOPMENTS
29 RELATED REPORTS
30 CONCLUSION
31 QUESTIONNAIRE
32 ABOUT DATA BRIDGE MARKET RESEARCH
